Pharma Litigation Attorneys Pen Article for Law360
Taft Chicago Pharmaceutical and Life Sciences Litigation attorneys Stephen Auten and Jaimin Shah along with Sinchan Shah of Amneal Pharmaceuticals Pvt. Ltd. published “For Now, Competitive Generic Therapy Exclusivity is a Mirage” for Law360. The article discusses issues with competitive generic therapy exclusivity enacted in the Food and Drug Reauthorization Act of 2017.
In This Article
You May Also Like
Taft Recognized in Top 10 in 2024 Lex Machina Trade Secret Litigation Report Lafeber, Lutz, and Peluchette to Serve on Panel at 2024 Midwest IP Institute